The global market for hemostasis products presently features the rising introduction of innovative and technologically advanced products, increased patent expiries and the resulting surge in biosimilars and cheaper alternatives, and increased demand across developing economies. Factors such as the vast rise in trauma and surgery cases and the increased investment in research and development activities will help in the favorable development of the market in years to come.

Transparency Market Research states that the global hemostasis products market will expand at a healthy 4.2% CAGR over the period between 2016 and 2024. Growing at this pace, the market, which had a valuation of US$5.35 bn in 2015, is expected to rise to US$7.73 bn in 2024.

Infusible Hemostats Presently Lead but Advanced Hemostats to Witness Promising Growth

Infusible hemostats are among the most common and widely used hemostatic products for a number of bleeding management practices performed on patients suffering from blood clotting disorders such as hemophilia, Von Willebrand disease (vWD), and dysfibrinogenemia. The segment thus held the largest share of over 47% in the global hemostasis products market in 2015. However, the segment is expected to lose its attractiveness and a vast share of its present share in the global market to the segment of advanced hemostats over the period between 2016 and 2024. Over this period, the market for advanced hemostats is expected to rise at a 6.9% CAGR, while segment of infusible hemostats will exhibit a meagre 07% CAGR.   

Hemostasis Products Used for Treatment of Hemophilia to Remain Key Contributor to Market’s Growth

Of the key application areas for hemostasis products, including trauma, surgery, hemophilia, myocardial infraction, stroke, and thrombosis, the use of hemostasis products for the treatment of hemophilia was the leading contributor to the global market’s overall revenues in 2015. The segment held an opportunity of US$5.35 bn in 2015 and is expected to witness growth at a substantial pace over the forecasting horizon as well. However, the applications of hemostasis products for the management of trauma cases will be the most promising application segment for the global hemostasis products over the period between 2016 and 2024. Over this period, the segment will expand at a 6% CAGR as compared to the comparatively moderate 4% CAGR that the hemophilia application segment is expected to exhibit.

 

hemostasis-products-market

 

Vast Untapped Opportunities to Stimulate Demand for Hemostasis Products in Asia Pacific

North America is presently the largest market for hemostasis products, accounting for a 36.1% share in the global market’s revenues in 2015. The region is expected to witness expansion at a substantial pace over the next few years as well. High level of receptiveness to technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will keep North America at the forefront of the global hemostasis products market in the near future.

The rising numbers of trauma cases and complex surgeries, rising geriatric population and high investment is research and development are also driving the hemostasis products market in North America. The market for hemostasis products in Europe, which is the second largest contributor to the global hemostasis products market’s revenues, is also chiefly driven by the abovementioned factors.

Over the period between 2016 and 2024, the market for hemostasis products in Asia Pacific is expected to yield the most promising results for the global hemostasis products market. The vast and continuously rising set of under-served population suffering from bleeding disorders such as hemophilia, especially across developing economies such as India, is expected to boost the adoption of hemostasis products in Asia Pacific. It is estimated that India has the largest number of hemophilia patients in the world, 60-70% of which were undiagnosed in 2015. TMR analysts state that the hemostasis products market in Asia Pacific will expand at a strong CAGR of 5.2% across the key regional markets from 2016 through 2024.

Some of the key vendors operating in the global hemostasis products market are Integra LifeSciences Corporation, C. R. Bard, Inc., Abbott Laboratories, Baxter International, Inc., CSL Behring LLC, HemCon Medical Technologies, Inc., Grifols, S.A., Johnson & Johnson, Medtronic plc, and Pfizer, Inc.

Magnifying Prevalence of Chronic Diseases and Other Disorders to Propel the Growth of the Hemostasis Products Market

The hemostasis products market expects to observe promising growth across the assessment period of 2016-2024 on the back of the growing trauma and surgical cases. The technological advancements observed across the hemostasis products market will also serve as a game-changer. The growing number of cardiovascular diseases and disorders will act as robust pillars of growth.

  • Hemostasis is a process of stopping the flow of bleeding and keeping it within a damaged blood vessel. The products that help in improving the hemostasis procedure and the overall patient care are known as hemostasis products. The antonym of hemostasis is hemorrhage. The heightening utilization of hemostasis products to improve the healing process attracts immense growth for the hemostasis products market.
  • The expanding number of road accidents and magnifying number of road accidents around the world are bringing tremendous growth opportunities. The cases of hemophilia are also rising at a rapid rate. As hemostasis products are used for treating hemophilia, this factor will invite good growth opportunities during the assessment period of 2016-2024.
  • The focus of the government bodies of various countries on healthcare expenditure will serve as a game-changer for the hemostasis products market. The growing investments in the healthcare sector by various government and non-government companies bode well for the growth of the hemostasis products market.
  • The novel coronavirus pandemic has affected the growth prospects of the hemostasis products market to a certain extent. The rising transmission rate of the virus forced many countries to go into stringent lockdowns. These lockdowns had a grave impact on many businesses and sectors across the globe.
  • Although no major loss was observed during the strict lockdown period, the border restrictions disrupted the supply chain and logistics, eventually ruining the growth to a certain extent.  The relaxations in restrictions will help in enhancing the revenues of the players in the hemostasis products market.

1. Preface
    1.1. Report Description
    1.2. Market Segmentation
    1.3. Research Methodology
    1.4. Assumptions

2. Executive Summary
    2.1. Global Hemostasis Products Market Revenue, by Product, 2015 & 2024 (Value %)    
    2.2. Global Hemostasis Products Market Revenue, by Geography, 2015 & 2024 (Value %)
    2.3. Global Hemostasis Products Market, 2015 & 2024: Market Snapshot 

3. Global Hemostasis Products Market Overview
    3.1. Overview    
    3.2. Market Dynamics
          3.2.1. Drivers
                   3.2.1.1. Driver 1 - Extensive research & technological advancements
                   3.2.1.2. Driver 2 - Increasing number of trauma and surgical cases
          3.2.2. Restraints
                   3.2.2.1. Restraint 1 - Stringent regulatory policies
                   3.2.2.2. Restraint 2 - Patent loss and increasing use of off-label products
          3.2.3. Opportunities
                   3.2.3.1.  Opportunity 1 - Emerging market in developing countries
                   3.2.3.2. Opportunity 2 - Visible pipeline of new products
    3.3. Market Attractiveness Analysis: Global Hemostasis Products Market, by Geography, 2015
    3.4. Competitive Landscape: Hemostasis Products Market, 2015 (Value %)

4. Global Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024 
    4.1. Overview    
    4.2. Global Topical Hemostasis Product Revenue, by Product type, (US$ Mn), 2014–2024
          4.2.1. Global Collagen Market Revenue, (US$ Mn), 2014–2024 
          4.2.2. Global Oxidized Regenerated Cellulose Market Revenue, (US$ Mn), 2014–2024
          4.2.3. Global Gelatin Market Revenue, (US$ Mn), 2014–2024
          4.2.4. Global Polysaccharides Market Revenue, (US$ Mn), 2014-2024
    4.3. Global Infusible Hemostasis Products Revenue, by Product type, (US$ Mn), 2014–2024
          4.3.1.  Global Fresh Frozen Plasma (FFP) Market Revenue, (US$ Mn), 2014–2024
          4.3.2. Global Platelet concentrate from donor blood Market Revenue, (US$ Mn), 2014–2024
          4.3.3. Global Factor VIII derived from blood Market Revenue, (US$ Mn), 2014–2024
          4.3.4. Global Prothrombin complex Market Revenue, (US$ Mn), 2014–2024
    4.4. Global Advanced Hemostasis Products Revenue, by Product type, (US$ Mn), 2014–2024
          4.4.1.  Global Flowable complex Market Revenue, (US$ Mn), 2014–2024
          4.4.2. Global Thrombin complex Market Revenue, (US$ Mn), 2014–2024
          4.4.3. Global Fibrin complex Market Revenue, (US$ Mn), 2014–2024
          4.4.4. Global Synthetic Sealants Market Revenue, (US$ Mn), 2014–2024

5. Global Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024 
    5.1. Overview
    5.2. Global Hospital Market Revenue, (US$ Mn), 2014–2024 
    5.3. Global Clinic Market Revenue, (US$ Mn), 2014–2024

6. Global Hemostasis Products Market Revenue (US$ Mn), by Application, 2014–2024
    6.1. Overview
    6.2. Global Trauma Market Revenue, (US$ Mn), 2014–2024 
    6.3. Global Surgery Market Revenue, (US$ Mn), 2014–2024
    6.4. Global Hemophilia Market Revenue, (US$ Mn), 2014–2024
    6.5. Global Myocardial Infarction Market Revenue, (US$ Mn), 2014–2024
    6.6. Global Stroke Market Revenue, (US$ Mn), 2014–2024
    6.7. Global Thrombosis Market Revenue, (US$ Mn), 2014–2024

7. Global Hemostasis Products Market Revenue (US$ Mn), by Geography, 2014–2024
    7.1. Overview
    7.2. Global Hemostasis Products Market : by Geography, 2014–2024 (US$ Mn)
    7.3. North America
          7.3.1. North America Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
                   7.3.1.1.  U.S.
                   7.3.1.2. Canada
          7.3.2. North America Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
                   7.3.2.1.  Topical Hemostats
                   7.3.2.2.  Infusible Hemostats
                   7.3.2.3.  Advanced Hemostats
          7.3.3. North America Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
                   7.3.3.1.  Hospitals
                   7.3.3.2.  Clinics
    7.4. Europe
          7.4.1. Europe Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
                   7.4.1.1.  U.K.
                   7.4.1.2. Germany
                   7.4.1.3. Rest of Europe 
          7.4.2. Europe Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
                   7.4.2.1.  Topical Hemostats
                   7.4.2.2.  Infusible Hemostats
                   7.4.2.3.  Advanced Hemostats
          7.4.3. Europe Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
                   7.4.3.1.  Hospitals
                   7.4.3.2.  Clinics
    7.5. Asia Pacific
          7.5.1. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
                   7.5.1.1.  China
                   7.5.1.2.  Japan
                   7.5.1.3.  Rest of APAC
          7.5.2. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
                   7.5.2.1.  Topical Hemostats
                   7.5.2.2.  Infusible Hemostats
                   7.5.2.3.  Advanced Hemostats
          7.5.3. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
                   7.5.3.1.  Hospitals
                   7.5.3.2.  Clinics
    7.6. Latin America
          7.6.1. Latin America Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
                   7.6.1.1.  Brazil
                   7.6.1.2.  Mexico
                   7.6.1.3.  Rest of LATAM 
          7.6.2. Latin America Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
                   7.6.2.1.  Topical Hemostats
                   7.6.2.2.  Infusible Hemostats
                   7.6.2.3.  Advanced Hemostats
          7.6.3. Latin America Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
                   7.6.3.1.  Hospitals
                   7.6.3.2.  Clinics
    7.7. Rest of the World
          7.7.1. Rest of the World Hemostasis Products Market Revenue, (US$ Mn), 2014–2024
          7.7.2. Rest of the World Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
                   7.7.2.1.  Topical Hemostats
                   7.7.2.2.  Infusible Hemostats
                   7.7.2.3.  Advanced Hemostats
          7.7.3. Rest of the World Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
                   7.7.3.1.  Hospitals
                   7.7.3.2.  Clinics

8. Company Profiles
    8.1. Abbott Laboratories
          8.1.1. Company Details
          8.1.2. Business Overview
          8.1.3. Product Portfolio
          8.1.4. Financial Overview
          8.1.5. Business Strategies
          8.1.6. Recent Developments
    8.2. Baxter International, Inc.
          8.2.1. Company Details
          8.2.2. Business Overview
          8.2.3. Product Portfolio
          8.2.4. Financial Overview
          8.2.5. Business Strategies
          8.2.6. Recent Developments
    8.3. C. R. Bard, Inc.
          8.3.1. Company Details
          8.3.2. Business Overview
          8.3.3. Product Portfolio
          8.3.4. Financial Overview
          8.3.5. Business Strategies
          8.3.6. Recent Developments
    8.4. CSL Behring LLC
          8.4.1. Company Details
          8.4.2. Business Overview
          8.4.3. Product Portfolio
          8.4.4. Financial Overview
          8.4.5. Business Strategies
          8.4.6. Recent Developments
    8.5. Grifols, S.A.
          8.5.1. Company Details
          8.5.2. Business Overview
          8.5.3. Product Portfolio
          8.5.4. Financial Overview
          8.5.5. Business Strategies
          8.5.6. Recent Developments
    8.6. HemCon Medical Technologies, Inc.
          8.6.1. Company Details
          8.6.2. Business Overview
          8.6.3. Product Portfolio
          8.6.4. Financial Overview
          8.6.5. Business Strategies
          8.6.6. Recent Developments
    8.7. Integra LifeSciences Corporation
          8.7.1. Company Details
          8.7.2. Business Overview
          8.7.3. Product Portfolio
          8.7.4. Financial Overview
          8.7.5. Business Strategies
          8.7.6. Recent Developments
    8.8. Johnson & Johnson
          8.8.1. Company Details
          8.8.2. Business Overview
          8.8.3. Product Portfolio
          8.8.4. Financial Overview
          8.8.5. Business Strategies
          8.8.6. Recent Developments
    8.9. Medtronic plc
          8.9.1. Company Details
          8.9.2. Business Overview
          8.9.3. Product Portfolio
          8.9.4. Financial Overview
          8.9.5. Business Strategies
          8.9.6. Recent Developments
    8.10.  Pfizer, Inc.
          8.10.1. Company Details
          8.10.2. Business Overview
          8.10.3. Product Portfolio
          8.10.4. Financial Overview
          8.10.5. Business Strategies
          8.10.6. Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global Hemostasis Products Market
TABLE 2 Global Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 3 Global Topical Hemostasis Product Market Revenue, by Product type, (US$ Mn), 2014–2024 
TABLE 4 Global Infusible Hemostasis Product Revenue, by Product type, (US$ Mn), 2014–2024 
TABLE 5 Global Advanced Hemostasis Product Market Revenue, by Product type, (US$ Mn), 2014–2024 
TABLE 6 Global Hemostasis Products Market, by End user, (US$ Mn), 2014–2024 
TABLE 7 Global Hemostasis Products Market Revenue, by Application, (US$ Mn), 2014–2024 
TABLE 8 Global Hemostasis Products Market, by Geography, (US$ Mn), 2014–2024
TABLE 9 North America Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 10 North America Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 11 North America Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 12 Europe Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 13 Europe Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 14 Europe Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 15 Asia Pacific Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 16 Asia Pacific Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 17 Asia Pacific Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 18 Latin America Hemostasis Products Market Revenue, by Country, (US$ Mn), 2016–2024
TABLE 19 Latin America Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 20 Latin America Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 21 Rest of the World Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 22 Rest of the World Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024

 

List of Figures

FIG. 1 Hemostasis Products Market Segmentation
FIG. 2 Global Hemostasis Products Market Revenue, by Product type, 2015 and 2024 (Value %)
FIG. 3 Global Hemostasis Products Market Revenue, by Geography, 2015 (Value %)
FIG. 4 Global Hemostasis Products Market Revenue, by Geography, 2024 (Value %)
FIG. 5 Market Attractiveness Analysis: Global Hemostasis Products Market, by Geography, 2014
FIG. 6 Global Hemostasis Products Market: Market Share Analysis, By Key Players, 2015 (Value %)
FIG. 7 Global Collagen Market Revenue, (US$ Mn), 2014–2024
FIG. 8 Global Oxidized Regenerated Cellulose Market Revenue, (US$ Mn), 2014–2024
FIG. 9 Global Gelatin Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Global Polysaccharide Market Revenue, (US$ Mn), 2014–2024
FIG. 11 Global Fresh Frozen Plasma Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Global Platelet concentrate from donor Market Revenue, (US$ Mn), 2014–2024
FIG. 13 Global Factor VIII from blood Market Revenue, (US$ Mn), 2014–2024
FIG. 14 Global Prothrombin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 15 Global Flowable Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 16 Global Thrombin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 17 Global Fibrin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 18 Global Synthetic Sealants Market Revenue, (US$ Mn), 2014–2024
FIG. 19 Global Hospitals Market Revenue, (US$ Mn), 2014–2024
FIG. 20 Global Clinics Market Revenue, (US$ Mn), 2014–2024
FIG. 21 Global Trauma Market Revenue, (US$ Mn), 2014–2024 
FIG. 22 Global Surgery Market Revenue, (US$ Mn), 2014–2024 
FIG. 23 Global Hemophilia Market Revenue, (US$ Mn), 2014–2024 
FIG. 24 Global Myocardial Infarction Market Revenue, (US$ Mn), 2014–2024 
FIG. 25 Global Stroke Market Revenue, (US$ Mn), 2014–2024 
FIG. 26 Global Thrombosis Market Revenue, (US$ Mn), 2014–2024 
FIG. 27 Rest of the World Hemostasis Products Market Revenue, (US$ Mn), 2014–2024
FIG. 28 Abbott Laboratories: Financial Overview (US$ Mn), 2013–2015
FIG. 29 Baxter International, Inc.: Financial Overview (US$ Mn), 2013–2015
FIG. 30 C. R. Bard, Inc.: Financial Overview (US$ Mn), 2013–2015
FIG. 31 CSL Behring LLC: Financial Overview (US$ Mn), 2013–2015
FIG. 32 Grifols, S.A.: Financial Overview (US$ Mn), 2013–2015
FIG. 33 Integra LifeSciences Corporation: Financial Overview (US$ Mn), 2013–2015
FIG. 34 Johnson & Johnson Group of Companies: Financial Overview (US$ Mn), 2013–2015
FIG. 35 Medtronic plc: Financial Overview (US$ Mn), 2013–2015
FIG. 36 Pfizer, Inc.: Financial Overview (US$ Mn), 2013–2015

 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Hemostasis Products Market